Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1333 (3 June), doi:10.1136/bmj.332.7553.1333
| The first 150 words of the full text of this article appear below. |
EDITORAn increase in empyema thoracis complicating pneumonia in children was reported from the West Midlands in 19971 and has since been confirmed in several other centres in the United Kingdom, Europe, and North America. Most culture positive cases in the United States are related to infection with Streptococcus pneumoniae serotype 1.2 This is also the most common causative organism in the UK where most cases are culture negative as shown by using pneumococcal polymerase chain reaction and serotype specific enzyme linked immunosorbent assays.3 Until recently, serotype 14 was responsible for most invasive pneumococcal disease in UK children, so the dominant serotype seems to have shifted considerably.
We have observed a further progressive increase in cases since 1997; over the past 12 months the number of cases requiring surgical intervention nearly doubled, to 48 per year. The figure shows the numbers of children requiring surgical intervention who represent 90%
David A Spencer, consultant respiratory paediatrician
david.spencer@nuth.northy.nhs.uk, Regional Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne NE7 7DN
Shaikh Mohammed Iqbal, specialist registrar in paediatrics, Asif Hasan, consultant cardiothoracic surgeon, Leslie Hamilton, consultant cardiothoracic surgeon
Regional Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne NE7 7DN